Korean Market
OWNR
WELCRON HANTEC
★

Welcron Increases Stake in Welcron Hantec to 35.41 Percent Strengthening Control

 
EXCH
Enplus
★

Enplus Files Self-Disclosure on Listing Eligibility Improvement Plan, Granted Grace Period but Delisting Risk Remains High

 
EXCH
Hyosung Chemical
★

Hyosung Chemical Implements Management Improvement Plan to Strengthen Financial Structure and Business Continuity, What Impact on Shareholder Value

 
EXCH
Enzychem Lifesciences
★

Enzychem Lifesciences Calls Temporary Shareholders Meeting to Elect New Directors and Amend Articles, Aiming to Restore Governance and Enter Real Estate Development

 
OWNR
TOPTEC
★

TOPTEC CEO Jiyong Jeong Buys 10,000 Shares, Stake Edges to 0.08 Percent, Signaling Confidence but Limited Market Impact

 
EXCH
Enplus
★

Enplus Faces Delisting Risk as KRX Grants Improvement Period and Maintains Trading Suspension After Corporate Review Committee Decision

 
MATR
Omnisystem
★

Omnisystem Announces 2 Billion KRW Treasury Stock Acquisition to Boost Shareholder Value, Representing 5.4% of Outstanding Shares

 
OWNR
Hyundai-Rotem
★

Hyundai-Rotem Unregistered Executive Choi Byung-hee Acquires 165 Shares via Open Market Purchase — Minimal Impact on Shareholder Value

 
EXCH
L&C BIO
★

L&C BIO Corrects Audit Report, Adjusts Financial Liability Valuation Loss to 85.7 Billion Won and Reports Consolidated Net Loss of 138.2 Billion Won

 
OWNR
Hyundai-Rotem
★

Hyundai-Rotem Non-Registered Executive Jeong Chang-seon Buys 270 Shares in Open Market, Negligible Impact on Shareholder Value

 
OWNR
WELCRON HANTEC
★

Insider Shin Jeong-jae increases WELCRON HANTEC stake by 23,800 shares to 1.40%, signaling confidence amid recent price decline

 
OWNR
GRT
★

Xinruixiang Holding Sells 1.5 Million GRT Shares in Block Deal to Secure Overseas Liquidity

 
EXCH
DHX Company
★

DHX Company Withdraws 14.5 Billion KRW Asset Acquisition, Eliminating Dilution Risk from Convertible Bonds

 
OWNR
Hyundai-Rotem
★

Hyundai Rotem Non-Registered Executive Jeong Seung-woo Acquires 150 Shares via Open Market Purchase, a Minor Positive Signal

 
OTHR
Enzychem Lifesciences
★

Outside Director Resignation Reduces Ratio from 50% to 33%, Raising Governance Concerns